MV Capital Management’s Novo Nordisk NVO Stock Holding History

MV Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.58K	Buy	158 +11	+7%	+$473	﹤0.01%	580
2026 Q1	$5.4K	Buy	147 +93	+172%	+$4.41K	﹤0.01%	609
2025 Q4	$2.75K	Buy	54 +34	+170%	+$1.74K	﹤0.01%	679
2025 Q3	$1.11K	Hold	20	–	–	﹤0.01%	783
2025 Q2	$1.38K	Hold	20	–	–	﹤0.01%	743
2025 Q1	$1.39K	Hold	20	–	–	﹤0.01%	724
2024 Q4	$1.72K	Hold	20	–	–	﹤0.01%	702
2024 Q3	$2.38K	Hold	20	–	–	﹤0.01%	684
2024 Q2	$2.85K	Hold	20	–	–	﹤0.01%	642
2024 Q1	$2.57K	Hold	20	–	–	﹤0.01%	651
2023 Q4	$2.07K	Hold	20	–	–	﹤0.01%	644
2023 Q3	$1.82K	Hold	20	–	–	﹤0.01%	639
2023 Q2	$1.62K	Hold	20	–	–	﹤0.01%	645
2023 Q1	$1.59K	Hold	20	–	–	﹤0.01%	654
2022 Q4	$1.35K	Hold	20	–	–	﹤0.01%	633
2022 Q3	$1K	Hold	20	–	–	﹤0.01%	662
2022 Q2	$1K	Hold	20	–	–	﹤0.01%	660
2022 Q1	$1K	Buy	+20	New	+$1.03K	﹤0.01%	684
2019 Q1	–	Sell	-7,200	Closed	-$166K	–	363
2018 Q4	$166K	Sell	7,200 -300	-4%	-$6.67K	0.05%	101
2018 Q3	$177K	Hold	7,500	–	–	0.04%	105
2018 Q2	$173K	Hold	7,500	–	–	0.04%	102
2018 Q1	$185K	Buy	+7,500	New	+$197K	0.05%	99

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MV Capital Management's NVO Position: Q2 2026 in Review

MV Capital Management increased its Novo Nordisk (NVO) stake by 7.5% in Q2 2026, buying an estimated $473 and bringing the position to 158 shares worth $7.58K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

MV Capital Management first reported a position in NVO in Q1 2018 and has held it in 22 quarters since. The position peaked at $185K in Q1 2018. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

MV Capital Management held 158 shares of Novo Nordisk worth $7.58K as of Q2 2026.
MV Capital Management bought 11 Novo Nordisk shares in Q2 2026, an estimated $473.
Novo Nordisk made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #580 holding.
MV Capital Management first reported a position in Novo Nordisk in Q1 2018 and has held it in 22 quarters since.
MV Capital Management's Novo Nordisk position peaked at $185K in Q1 2018.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.